baber/WOPTO huggingface dataset:
Patent NZ-331376-A (NZ)
Title: Methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
Inventor: CAPON DANIEL J
IPC: C12Q1/68
Filed: 1997-01-29
Abstract: This invention provides a method for determining susceptibility for an anti-viral drug comprising: (a)	introducing a resistance test vector comprising a patient-derived segment and an indicator gene into a host cell; (b)	culturing the host cell from (a); (c)	measuring expression of the indicator gene in a target host cell; and (d)	comparing the expression of the indicator gene from (c) with the expression of the indicator gene measured when steps (a)-(c) are carried out in the absence of the anti-viral drug, wherein a test concentration of the anti-viral drug is present at steps (a)-(c); at steps (b)-(c); or at step (c). This invention also provides a method determining anti-viral drug resistance in a patient. This invention also provides a method for evaluating the biological effectiveness of a candidate anti-viral drug compound. Compositions including resistance test vectors comprising a patient-derived segment and an indicator gene and host cells transformed with the resistance test vectors are provided.
Patent NZ-333426-A (NZ)
Title: Conducting telephone polls, calls handled by service control point using service provider's data links
Inventor: WEISSER FRANK J
IPC: H04M3/22
Filed: 1997-06-24
Abstract: In an intelligent switched telephone network, a telephone polling method is provided where a  call made in response to a telephone based polling service is processed and disconnected without connection of the call to the subscriber of the polling service.  A call received in the network and directed to a number associated with a telephone polling service has its identification information read and compared to entries in a database of subscriber information for a matching entry.  The call is tabulated in the database as a response to the polling service poll or survey.  If desired by the polling service subscriber, the calling party may be provided with a caller interaction program through which the calling party may select from a variety of responses.  If desired, the calling party may be provided with a call termination announcement.
Patent NZ-335415-A (NZ)
Title: Protection circuit for resistive heating element using differential current transformer and small short circuit bias current in conjunction with relay
Inventor: BUTLER RICHARD GEORGE ARTHUR
IPC: H02H3/347
Filed: 1998-01-30
Abstract: A small bias current is supplied through resistor 132.  If earth leakage occurs current difference transformer 126 and other circuit elements release power from relay 131 so that switch 124 opens.  If a fault develops current through resistor 132 is not sensed and the circuit elements prevent switch being reactivated.
Patent NZ-335481-A (NZ)
Title: A valve assembly
Inventor: PETERSEN POUL SKADBORG
IPC: F16K31/122
Filed: 1997-11-07
Abstract: A valve assembly unit is described.  The unit is best illustrated by Fig.  Fig 1 is a side view of a valve assembly according to the invention, partly in section,  The valve assembly 1 shown in Fig. 1 is substantially formed in three parts, viz. a valve 2, an actuator 3 with a head 4, and a control unit 5.  The valve 2 serves for instance to conduct a fluid or a gas from a tube 6 to another tube 7. The valve 2 can be closed by means of a valve cone 8 which is made to abut a valve seat 9, the valve cone 8 communicating with a valve spindle 10. The actuator 3 is a cylinder 11 with a piston 12 whose axis 13 is co-axial with the valve spindle 10 mechanically connected to the piston 12. As a result the position of the valve cone 8 in relation to the valve seat 9 can be determined by means of the position of the piston 12 in the actuator 3.  The head 4 of the actuator 3 is secured to the end of the actuator 3 facing away from the valve 2 by means of bolts 14 and according to the invention is to be considered as a part of the actuator.  In the shown embodiment the piston 12 is moved upwards in the direction away from the valve 2 by means of a spring 15. The movement of the piston 12 toward the valve 2 for closure hereof is obtained by means of an air pressure supplied from the control unit 5 through a hose or a tube 16.
Patent NZ-500018-A (NZ)
Title: Diffusional implantable delivery system with capillary tube of cross-sectional area and length to deliver beneficial agent
Inventor: TZANNIS STELIOS T
IPC: A61K31/445
Filed: 1998-03-17
Abstract: A sustained release delivery system for delivering a beneficial agent is provided. The system includes a reservoir comprising the beneficial agent and a capillary channel in communication with the reservoir and the exterior of the system for delivering the beneficial agent from the system. The capillary channel has a cross-sectional area and a length selected to deliver the beneficial agent at a predetermined rate. The system may further include an outer surface that is impermeable and non-porous during delivery of the beneficial agent. The beneficial agent may be formulated in a glassy sugar matrix
Patent NZ-505769-A (NZ)
Title: Enhancement of metal molluscicides by ethylene diamine disuccinic acid
Inventor: PURITCH GEORGE S
IPC: C05G3/60
Filed: 1999-02-04
Abstract: An ingestible mollusc poison containing a simple metal compound, an activity-enhancing additive such as ethylene diamine disuccinic acid (EDDS) and derivatives thereof, and a carrier material edible to molluscs. In one embodiment the active agent of the mollusc poison may be in the form of a metal complex of EDDS. The composition may be used alone or in conjunction with molluscicidal co-active agents and/or fertilizers.
Patent NZ-505948-A (NZ)
Title: Propofol composition containing sulfite as a preservative to prevent bacterial growth of Staphylococcus, Escherichia, Pseudomonas and Candida
Inventor: MIREJOVSKY DORLA
IPC: A61P23/00
Filed: 1999-02-10
Abstract: A sterile pharmaceutical composition for parenteral administration comprising an oil-in-water emulsion in which propofol is dissolved in a water-immiscible solvent, is emulsified in with water and is stabilized by means of a surfactant; and which further comprises an amount of sulfite (e.g. sodium metabisulfite) sufficient to prevent no more than a 10-fold increase in the growth of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans for at least 24 hours.
Patent NZ-506261-A (NZ)
Title: Liner for preform with mounting on liner to engage inner male mold member
Inventor: DARR RICHARD C
IPC: B29C49/00
Filed: 1999-01-28
Abstract: A multi-layer preform (10) is provided which includes: (a) a plastic inner liner (30), having a cylindrical- walled lower portion and a cylindrical-walled upper portion integral with and extending upwardly from said lower portion, and a molded outer layer. The liner further includes (a) a mount means (78), such as a generally continuous annular groove. The perform may also have a vent means, such as a plurality of recesses or grooves (not shown) positioned circumferentially about the upper portion of the liner, or both a mount means and vent means used in functional combination.
Patent NZ-511768-A (NZ)
Title: Froth pump having a froth impeller with flow inducing blades that project beyond the free edge of the pumping blades
Inventor: BURGESS KEVIN EDWARD
IPC: F04D29/30
Filed: 1999-11-05
Abstract: An impeller (10) suitable for use in a centrifugal pump (50), the pump (50) including a pump chamber (54) and a pump inlet (56). The impeller (10) includes a main body portion (12) which includes a plurality of primary pumping blades (16) or vanes and one or more flow inducing blades (20) or vanes which project from the main body portion (12) of the impeller (10) and when installed into the pump inlet (56).
Patent NZ-511900-A (NZ)
Title: Sustained release matrix systems for highly soluble drugs
Inventor: BAICHWAL ANAND R
IPC: A61K9/22
Filed: 2000-09-29
Abstract: A sustained release oral solid dosage form comprises: a) a therapeutically effective amount of a medicament such as a calcium channel blocker having a solubility of more than 10 g/l; b) a pH modifying agent which is an organic acid such as fumaric acid and c) a sustained release granulate comprising a gelling agent. The gelling agent comprises a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking the heteropolysaccharide gum when exposed to an environmental fluid. The dosage form provides a sustained release of the medicament after oral administration to human patients and the pH modifying agent facilitates the release of the medicament from the dosage form.
Patent NZ-514770-A (NZ)
Title: Pulverizing apparatus with rotors having polygonal shape and radial vanes separated by orifice plates
Inventor: ARNOLD CHARLES A
IPC: B02C19/18
Filed: 1998-07-17
Abstract: Polygonal rotor plates 90, 92, 94, 96, 98, 100 have radial vanes 152 and are separated by orifice plates 128, 130, 132, 134, 136.
Patent NZ-515570-A (NZ)
Title: Hydrochloride of fused-heterocycle compound
Inventor: FUJITA TAKASHI
IPC: A61P3/06
Filed: 2000-05-24
Abstract: The use of 5-[4-(6-Methoxy-1-methyl-1H-benzimidazol-2- ylmethoxy)benzyl]-thiazolidin-2,4-dione hydrochloride as an active ingredient in a medicine for improving insulin resistance; treating or prophylaxis of hyperglycaemia, diabetic complications and impaired glucose tolerance.
Patent NZ-521007-A (NZ)
Title: A composition containing branched polymer defoamers and hydrophobic pigment dispersants
Inventor: BREINDEL KENNETH
IPC: C09K23/52
Filed: 2001-03-09
Abstract: Branched polymer defoamers for pigment dispersants are disclosed, wherein the branched polymers are the reaction products of: a) a linking agent defined by formula (I): R(Y)3, wherein each Y group is a halogen atom or one Y group is a halogen atom and two Y groups together represent an epoxy oxygen atom, which is attached to two adjacent carbon atoms in the R group to form an epoxy group, and -R- is an alkanetriyl group containing from 3 to 10 carbon atoms, and b) at least one compound having the formula (II): R1X(EO)n(PO)m(BO)pZ, wherein: R1 is a substituted or unsubstituted, saturated or unsaturated, organic group having from 4 to 36 carbon atoms; X is -O-, -S-, or -NR2- where R2 is hydrogen or a C1-C4 alkyl group; Z is hydrogen, -NHR2 in place of a terminal -O- group wherein R2 has the meaning given above, or -SH, in which -SH group is present in place of a terminal -O-group; n is a number of from 0 to 100, e.g., from 1 to 100; m is a number of from 0 to 50 e.g., from 1 to 50; and p is a number of from 0 to 50 e.g., from 1 to 50; provided that the sum of n, m, and p is at least 1; and wherein EO, PO and BO groups when present can be in random and/or block distribution and can be in any order with respect to the X group.
Patent NZ-524429-A (NZ)
Title: Catalytic antibodies and a method of producing same
Inventor: KOENTGEN FRANK
IPC: C12N9/00
Filed: 1998-09-18
Abstract: A growth factor precursor comprising an antigen capable of interacting with a B cell bound catalytic antibody, wherein said antigen is fused to a B cell surface molecule binding portion such that upon cleavage of the antigen mitogenesis of the B cell comprising the remainder of the precursor is induced thereby producing more of the catalytic antibody, is used in the manufacture of a medicament for the treatment of a condition mediated by the antigen or a gent comprising the antigen. (62) Divided out of 515603
Patent NZ-530172-A (NZ)
Title: New use of cyclolignans and new cyclolignans
Inventor: LARSSON OLLE
IPC: A61K31/365
Filed: 2002-06-19
Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9' have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1 R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.
Patent NZ-532030-A (NZ)
Title: Aryl aniline beta-2 adrenergic receptor agonists
Inventor: MORAN EDMUND J
IPC: C07D215/26
Filed: 2002-11-12
Abstract: Aryl aniline beta 2 adrenergic receptor agonist compounds of formula (I) are disclosed, wherein the substituents R1 to R13 and w are as described in the specification. Also disclosed are pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with beta 2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
Patent NZ-532332-A (NZ)
Title: Composition comprising brucine (2,3-dimethoxystrychindin-10-one) to be applied topically to treat damaged mamalian skin
Inventor: VILA ANTHONY
IPC: A61P17/02
Filed: 2002-09-18
Abstract: Disclosed herein is a use of brucine (2,3-dimethoxystrychnidin-10-one) or a dermatologically acceptable salt thereof, or a hydrate thereof, in the manufacture of a medicament for the treatment of damaged mammalian skin. Particularly disclosed is a dermatological composition suitable for topical application to mammalian skin, which comprises: (a) approximately 0.05-0. 3% by weight of brucine or a dermatologically acceptable salt thereof, or a hydrate thereof; (b) approximately 0.8-3% by weight of a hydroxy acid or a salt, ester or amide thereof; (c) approximately 0.15-5% by weight of water; and (d) the balance comprising a dermatologically acceptable oil or water or a combination thereof.
Patent NZ-537559-A (NZ)
Title: Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
Inventor: ZAHN RALPH
IPC: C07K14/47
Filed: 2003-07-05
Abstract: Described is a mutant of a protein or variant thereof which causes a disease after having performed a conformational transition. This disease comprises neurodegenerative diseases such as Transmissible Spongiform Encelphalopathy (TSE), Alzheimers disease, Multiple Sclerosis, and Parkinsons disease; and/or other conformational diseases such as Primary systematic amyloidosis, Type II diabetes, and Atrial amyloidosis. The mutant protein or a variant thereof comprises at least one additional engineered disulphide bond which inhibits a conformational transition od such proteins in humans and animals. Also described is a nucleic acid sequence coding for the mutant of the protein or variant and the use of the mutant protein, variant, or the nucleic acid in the preparation of a medicament for the treatment of conformational diseases.
Patent NZ-544616-A (NZ)
Title: Suitcase
Inventor: SELVI SEDAT
IPC: A45C7/00
Filed: 2004-06-25
Abstract: A method of constructing a hard suitcase including forming a shaped base portion (1) and a shaped lid portion (2) from a plastics material of such characteristics that the portions retain their intended shape, and attaching to each of the portions the respective zipped portions of a Zip fastener arrangement (16) by a stitching operation involving a securing thread. A further double Zip arrangement (25) provided between the Zip arrangement (16) and the lid portion enables an increase in the storage volume of the case.
Patent NZ-545830-A (NZ)
Title: Method for producing substrate having carbon-doped titanium oxide layer
Inventor: FURUYA MASAHIRO
IPC: C23C8/02
Filed: 2004-12-08
Abstract: Disclosed is a method for producing a substrate having a carbon-doped titanium oxide layer, characterized by heat-treating a surface of a substrate, which has at least a surface layer comprising titanium, a titanium alloy, a titanium alloy oxide, or titanium oxide, in a gas atmosphere containing at least 50% by volume of a hydrocarbon such that a surface temperature of the substrate is 900 to 1,500øC, thereby forming a carbon-doped titanium oxide layer in which the carbon is doped in a state of Ti-C bonds.
Patent NZ-548315-A (NZ)
Title: A memory device, an information storage process, a process, and a structured material
Inventor: WILLIAMS JAMES STANISLAV
IPC: G11C11/34
Filed: 2004-12-09
Abstract: A memory device has a plurality of memory cells for storing information. The memory cells including respective regions of a semiconductor. Information is stored in the regions as a corresponding arrangement of at least two measurably distinct phases of the semiconductor in the regions by applying pressure to and removing pressure from at least a subset of the regions to induce one or more phase transformations in those regions. A property of the plurality of regions is measured to determine the information stored in the regions. The property includes conductivity or resistance. Applying of pressure to and removing pressure from each region includes transforming the region from at least one first phase to at least one second phase. At least one of the first phase includes an amorphous phase and the at least one second phase includes at least one crystalline phase. The amorphous phase is a relaxed amorphous phase. At least one first phase includes at least one crystalline phase, and the at least one second phase includes an amorphous phase.
Patent NZ-551938-A (NZ)
Title: Fused heterocyclic compound
Inventor: ISHIKAWA TOMOYASU
IPC: A61K31/519
Filed: 2005-06-01
Abstract: Disclosed is a fused pyrimidine compound represented by the formula (I), wherein the substituents are as defined in the specification. The compound is a tyrosine kinase inhibitor useful as a preventive or therapeutic agent for cancer.
Patent NZ-552213-A (NZ)
Title: Non-recombinant saccharomyces strains that grow on xylose
Inventor: BELL PHILIP JOHN LIVINGSTONE
IPC: C12N15/04
Filed: 2005-06-08
Abstract: Disclosed are strains of Saccharomyces capable of growing at a growth rate of at least one generation per 48 hours use xylose as a sole carbon source for growth. Also disclosed are non-recombinant methods for producing said strains of Saccharomyces and the use of the strains in the production of ethanol.
Patent NZ-553785-A (NZ)
Title: Sound and vibration transmission pad and system
Inventor: COHEN DANIEL E
IPC: H04R5/02
Filed: 2005-09-15
Abstract: A pad including a speaker chamber, at least two acoustic speakers, and a number of layered materials is provided. The speaker chamber includes a resonant chamber. The materials have different degrees of acoustic conductance and compressibility. At least one of the acoustic speakers is located within the speaker chamber, and at least a portion of the speaker chamber is defined within an aperture extending through more than one material of the number of layered materials. At least a portion of the resonant chamber is configured to be positioned between at least one of the acoustic speakers and a user. A chair with pads is also provided.
Patent NZ-555161-A (NZ)
Title: Packaging articles and films comprising myoglobin blooming agent and methods that promote or preserve the desirable color of meat
Inventor: SIEGEL DAN G
IPC: A23L5/41
Filed: 2007-05-15
Abstract: Disclosed is a food packaging article having an interior surface and an exterior surface, wherein the article comprises: a food contact layer comprising a myoglobin blooming agent, wherein the myoglobin blooming agent is selected from nitric oxide donating compounds, nitrogen heterocycles or sulfur monoxide donating compounds; wherein the nitric oxide donating compound is selected from nitrosodisulfonates, transition metal/nitroso complexes, organic nitrates, organic nitrites, organic nitro compounds, organic nitroso compounds, O-nitrosylated compounds, S-nitrosylated compounds, nonoate compounds, furoxans, oxatriazole-5-imines, sydnonimines, oximes or combinations thereof; and an oxygen barrier layer.
Patent NZ-556198-A (NZ)
Title: Cushion for patient interface
Inventor: DAVIDSON AARON SAMUEL
IPC: A61M16/06
Filed: 2006-01-12
Abstract: A cushion for a patient interface, that delivers breathable gas to a patient, is disclosed. The cushion comprises, a base wall structured to be connected to a frame, an underlying support cushion extending away from the base wall towards the patient's face in use, and a membrane provided to substantially cover at least a portion of the underlying cushion. The membrane includes a nasal bridge, cheek, and chin regions that form a continuous seal on nasal bridge, cheek, and chin regions of the patient's face. The nasal bridge and adjacent cheek regions define an intersection where the membrane in the nasal bridge region is constructed and formed so that a centreline on an apex of the face-contacting side of the membrane has a substantially flat portion in elevation view.
Patent NZ-561754-A (NZ)
Title: Endoparasiticide composition containing emodepside and praziquantel or epsiprantel
Inventor: KANIKANTI VENKATA-RANGARAO
IPC: A01N43/84
Filed: 2006-02-27
Abstract: An endoparasitic composition comprising emodepside and praziquantel or epsiprantel. The solvent of the composition is 1,2-isopropylideneglycerol (solketal) that has a water content of at most 1%. This composition solves the problem of 1,2-isopropylidene glycol hydrolysing to form acetone by ensuring that the water content is below 1%. Also disclosed is the process for making the composition and the use of the composition for controlling endoparasites.
Patent NZ-563703-A (NZ)
Title: Wood chip flinger and method
Inventor: BAILEY KENNETH F
Filed: 2007-11-26
Abstract: Disclosed is an assembly for processing wood chips with a novel blade profile which allows wood chips to be packed to high density. The profile may be a stepped profile with a plurality of sections forming a rotationally forward face. Neighbouring sections are non-collinear and at least one of the sections is parallel to a rotational axis. The profile may include a generally centrally disposed first section of greater than or equal to one quarter of a relevant dimension; a third section of greater than or equal to one eighth of the relevant dimension; a second dimension disposed between the first section and a third section and non-collinear with the third section; with the sections disposed relative to the rotational axis in advantageous positions. The profile may be such that second and third sections of the blade have approximately equal longitudinal extents, but the tilt-angle-weighted surface of the second section is substantially less than the third tilt-angle-weighted surface area of the third section.
Patent NZ-567610-A (NZ)
Title: Saccharomyces exiguous having bad smell removal activity of organic waste and use thereof
Inventor: PARK SEE JOON
IPC: A01N63/32
Filed: 2006-10-19
Abstract: Provided are several microorganisms that are efficient at removing odour from organic waster. The microorganisms have the effects of preventing or removing the offensive odour from organic waster, killing noxious insects and plant pathogenic fungi, preventing decomposition, and promoting digestion and fermentation. The microorganisms can also be used as feed additives and antibiotic substitutes, and are also useful for the preparation for fermented healthy foods. The claimed microorganism is Saccharomyces exiguous SJP6728AF1 (KCCM-10675P).